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Abstract
Sepsis is a life-threatening organ dysfunction caused by an irregular host response
to infection. There are cytokines that regulate various inflammatory responses.
Dysregulation of cytokines causes endothelial dysfunction, vasodilation and increased
capillary permeability, then causes cellular leakage syndrome that interferes with
regulation and intravascular hypovolemia, cellular dysfunction, and ultimately tissue
death. As the main extracellular cation, sodium (Na) is the most osmotically active
solute in the human body. Sodium is usually a parameter that is ignored, but it has a
predictive value. This study aimed to evaluate the prognostic value of serum Na in adult
patients with a diagnosis of sepsis.A total of 406 patients were diagnosed with sepsis
during 2017 at Dr. Moewardi hospital. Data collection was performed in a retrospective
cohort during the period of January-December 2017. Data distribution was evaluated
by using Kolmogorov-Smirnov test, followed by Kruskal-Wallis analysis for comparison
between groups and by using chi-square test. We determined the relative risk (RR) to
assess the risk of death. We found that in patients with hypernatremia RR= 7.25 (95% CI
0.91-57.58; p = 0.03), in mild hyponatremia RR= 0.45 (95% CI 0.22 - 0.91; p= 0.02), both
were comparable to healthy control. In conclusion, there is no significant difference
in the risk of death between patients with hypernatremia group and normonatremia,
serum sodium levels are not the main parameters that indicate the risk of death but can
be used as a supporting parameter of risk of death in septic patients.
1. Introduction
Critical diseases such as severe burns, trauma, sepsis, brain damage, and heart failure
can cause fluid and electrolyte homeostasis. Acute disorders of sodium concentration
in blood, or dysnatremia (hyponatremia and hypernatremia), are usually found in inten-
sive care units (ICU) and have adverse effects on various organ systems especially
through changes in plasma osmolality [1]. The prevalence of dysnatremia is around 10-
20% of patients with critical illness [2] and the prevalence of hypernatremia around 25 -
45% varies around 25-45% according to the time of onset, threshold for diagnosis, and
population [3]. The definition of hyponatraemia and hypernatremia varies in different
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studies, but most studies defined hyponatraemia as a serum sodium level of less than
136 mmol/L, while hypernatremia is greater than 145 mmol/L [4].
Sepsis is defined as a life-threatening organ dysfunction caused by an irregular host
response to infection. Clinical criteria for sepsis include suspected infection or docu-
mented and acute increase of two or more of Sequential Organ Failure Assessment
(SOFA) as a reference for organ dysfunction. However, SOFA is a score calculation that
has many variables so that it is less applicable for routine use [5].
In sepsis, there are cytokines that regulates various inflammatory responses. Dysreg-
ulation of cytokine release causes endothelial dysfunction, vasodilation, and increased
capillary permeability which result in cellular leakage syndrome that interferes with fluid
regulation and causes intravascular hypovolemia, cellular dysfunction, and finally tissue
death. Hemodynamic changes in sepsis are directly related to endothelial disorders,
tissue hypoxia, mitochondrial dysfunction, decreased oxygen delivery, and changes
in blood flow [6]. Impaired renal function and the effects of fluid loss play important
roles in the increase of BUN and creatinine. Moreovers osmotic diuresis due to the
high concentration of urea in the blood can cause the kidneys losing free water thus
increasing serum sodium levels [4]. Sodium levels are controlled by the mechanism
of the arginine, kidney and brain vasopressin system. Abnormalities in serum sodium
indicate a disturbance in the body’s water balance. Such disorders can cause serious
clinical manifestations including seizures, coma and even death [7].
As a major extracellular cation, sodium is the most osmotically active solute in the
human body. Under normal conditions, serum sodium is maintained in the physiolog-
ical range. Even mild hypernatremia or acute changes in serum Na, can trigger rapid
changes in serum osmolality with poor results. So that it can give an explanation that
sodium as a parameter that is usually ignored can have predictive values [3].
Several previous studies associated sodium levels with sepsis, but still have weak-
nesses. In their study, Wu et.al. explained the important role of serum Na as a predictor
of mortality that can be relied upon patients with enteric fistula who had septic compli-
cations; however, the limitation of the study is that it was only conducted for 7 days in
certain population groups withmale sex dominance [8]. Another study [3] suggested that
one third of patients with critical illness experience mild to moderate dysnatremia when
entering ICU; the limitation is that the research design did not allow the evaluation of
the causes of dysnatremia and factors that influence the therapeutic and fluid balance.
This study aimed to determine the relationship of serum sodium levels as a predictor of
mortality in patients with sepsis.




This study was a retrospective cohort study to determine the relationship of serum
sodium levels with the risk of death in septic patients.
2.2. Place and time
The study was conducted in the clinical pathology laboratory of Dr. Moewardi Regional
General Hospital from January to December 2017.
2.3. Research population
The target population of this study were all patients diagnosed with sepsis based on
International Diagnostic Criteria (ICD) 10 by clinicians at Dr. Moewardi Surakarta between
January - December 2017 (total sampling for 1 year).
2.4. Research subjects and methods for taking research subjects
The research subjects were recruited by total sampling within the period of January -
December 2017, with the inclusion criteria being the data of patients diagnosed with
sepsis by the clinicians based on ICD-X and the subjects were examined for serum
sodium levels. We classified the clinical outcome of life and death that matched the
subjects of the study based on age parameters. The clinical outcome of the patient is
seen when the patient left the hospital; i.e., dead or alive. Exclusion criteria were septic
patients who left the hospital forcibly (on their own request).
2.5. Sample size
Data from a total of 406 sepsis patients admitted to DR Moewardi hospital from Jan-
uary to December 2017 were recorded. Analysis was carried out based on the time of
examination of serum sodium levels and based on the age of the patient (≥ 18 years).
Then, from 338 study subjects, exclusion criteria were re-examined; namely the clinical
outcome of patients discharged at their own request or forced return. Based on the
inclusion and exclusion criteria, there were 328 subjects included in this study.
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2.6. Patient data and laboratory examination
Demographic data were obtained from medical records. The parameters of serum
sodium were examined using the AVL electrolite analyzer with the ion-selective elec-
trode (ISE) method, the value ranges from 40-205mmol/L [9]. Data from the examination
of sodium levels were taken when the diagnosis of sepsis was established.
2.7. Identification of research variables
The variables in this study were serum sodium levels that were divided into several
groups according to the literature, namely: levels 135 until ≤145 mmol/L are called
normonatremia, levels ≤125 mmol/L are called severe hyponatremia, 125 until ≤129
mmol/L are called moderate hyponatremia, levels of 130 until ≤134 mmol/L are called
mild hyponatremia, and levels of >145 mmol/L are called hypernatremia [10]. The sepsis
type (specific or non-specific) was determined based on examination of blood cultures;
a specific sepsis is defined if germs were found and sepsis was not specific if no germs
were found or sepsis was considered due to other causes.
2.8. Statistical analysis
Characteristics of research subjects were presented in an observational analytic manner.
Test of data distribution was performed using Kolmogorov-Smirnov analysis, test of data
distribution shows that the data is not normally distributed so the data is presented as a
median, the minimum and maximum value. A comparison of sodium levels among more
than two groups of was carried out using the Kruskal-Wallis test. Statistical significa-
tion P <0.05. Categorical data uses chi-square and RR (relative risk) assessment using
descriptive analysis with SPSS version 16.0
3. Results
A total of 328 patients with a sepsis diagnosis who were treated within 1 year between
January 1, 2017 and December 31, 2017 who were examined for serum sodium levels
when diagnosed with sepsis were included in the analysis. Approximately 53.3% of the
research subjects were male. Median age is 58.14 years (range 21-93). Median length of
stay is 9.63 days (range 1 - 69). The mortality rate during the study lasted 76.83%.
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The mean value of serum Na 133 mmol / L (range 132.08 - 134.02). Measurement of
sodium levels is not normally distributed. Total normonatremia percentage was 22.86%;
while in the hypernatremia group it was 9.14%. The highest mortality value was in the
hypernatremia group 96.7% and severe hyponatraemia was 88.5%. Sepsis was divided
into two specific groups and was not significantly higher in the severe hyponatremia
group with non-specific sepsis of 78.8% (p = 0.019) (Table 1). There is a significant differ-
ence between survival rate compared to those who died in the sodium group with the
value of p <0.001 (Table 2)


















61 56.5 58 60.5 57
Range (26 - 87) (24 - 88) (21 - 89) (24 - 93) (21 - 93)
Gender 0.984
Male (%) 41 (54.7) 29 (55.8) 37 (50.7) 52 (53.1) 16 (53.3)




Median (day) 7 7.5 6 9 8.5
Range (1 - 55) (1 - 48) (1 - 69) (1 - 48) (1 - 55)
Sepsis 0.019
Specified (%) 26 (34.7) 11 (21.2) 17 (23.3) 37 (37.8) 14 (46.7)
Unspecified
(%)
49 (65.3) 41 (78.8) 56 (76.7) 61 (62.2) 16 (53.3)
Mortality (%) 60 (80) 46 (88.5) 54 (74) 63 (64.3) 29 (96.7) 0.001
The Kruskall-Wallis test is significant if p <0.05
The RR value of the hypernatremic group was 7.25 (95% CI 0.91-57.58) (p = 0.03) and
in the mild hyponatremia group RR value was 0.45 (95% CI 0.22 - 0.91) (p = 0.02) (Table
3).
4. Discussion
Hai-bin study found that clinical patients with hypernatremia were significantly worse
than the non-hypernatremia group [4]. The results of the study by Atalan, that APACHE
value (acute physiology and chronic health evaluation) II, SOFA score, low and high pH
value, hypernatremia, hyperlactatemia, and low Cl: Na ratio are predictors of increased
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Table 2: Comparison of research subjects: survive vs died.
Survive Died P value
Count (%) 76 (23.17) 252 (76.83) -
Sodium group < 0.001
Normonatraemi 15 (20) 60 (80)
Severe hyponatraemic 6 (11.54) 46 (88.46)
Moderate hiponatraemic 19 (26.03) 54 (73.97)
Mild hiponatraemic 35 (35.71) 63 (64.29)
Hypernatraemic 1 (3.33) 29 (96.67)
Length of stay 0.006




Range (57.1 - 63.6) (55.4 – 58.9)
Sepsis 0.19
Specified (%) 29 (27.36) 77 (72.64)
Unspecified (%) 47 (21.08) 176 (78.92)
Gender 0.36
Male (%) 43 (24.85) 130 (75.15)
Female (%) 33 (21.15) 123 (78.85)
The Chi Square test is significant if p <0.05
Table 3: The relationship between normonatraemia and disnatremia with the risk of death in septic patients.
P value
Normonatraemic (Na 135 - 145 mmol/L)
RR 1 -
95 % CI - -
Severe hiponatraemic (Na < 125 mmol/L)
RR 1.92 0.21
95 % CI 0.69 - 5.32
Moderate hiponatraemic (Na 125 - 129
mmol/L)
RR 0.71 0.38
95 % CI 0.33 - 1.54
Mild hiponatraemic (Na 130 - 134 mmol/L)
RR 0.45 0.02
95% CI 0.22 - 0.91
Hipernatraemic (Na > 145 mmol/L)
RR 7.25 0.03
95% CI 0.91 - 57.58
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mortality in ICU [11]. In this study, the RR value of the hypernatremia group was 7.25 (95%
CI 0.91-57.58) (p = 0.03) meaning that there were no significant differences in the risk of
death between patients with hypernatremia and normonatremia groups. It can be said
that serum sodium level is not the main parameter that indicate the risk of death, but
can be used as a risk support parameter for death which refers to the main laboratory
criteria and parameter for the diagnosis of sepsis.
In the Whelan study, there was a significant association between hyponatremia and
the risk of death in hospital despite adjustment for acute disease scores, age, criteria for
sepsis, ICU admission and pre-transfusion requirements, all of which were strong predic-
tors of hospital mortality [7]. Clayton’s study in 108 patients with severe hyponatraemia
obtained a hospital mortality rate of 20%, compared with normonatremic patients with
7% of mortality over the same period of time. Interestingly, about 2 years later, the
mortality rate increased to 45% in the severe hyponatremia group compared to only
22% in normonatremia patients [12]. However, this study found a mild hyponatremia
group with RR 0.45 (95% CI 0.22 - 0.91, p = 0.02), meaning that mild hyponatremia was
a protective factor against the occurrence of death in septic patients, the risk of death
in the hyponatremia group was 2.2 times more low compared to normonatremi group.
5. Study Limitations
The retrospective cohort study design posed a difficult determination when subjects
are exposed to the risk factors studied. The diagnosis of sepsis is made by different
clinicians so that there was no standardization. Moreover, the proportion of each group
is unbalanced. In this study, we did not control other factors that could influence clinical
outcomes, such as APACHE II score, SAPS (simplified acute physiology score) score and
BMI (body mass index). This study also did not exclude the diagnosis that can affect
the levels of the parameters studied (e.g., shock patients, hypoxemia, seizures, chronic
kidney disease, dehydration, heavy activities that can affect blood sodium levels).
6. Conclusion
In this study, it can be concluded that there is no significant difference in the risk of death
between patients with hypernatremia and those with normonatremia so serum sodium
level is not the main parameter that indicates the risk of death but can be used as a
supporting parameter of risk of death in septic patients. In mild hyponatraemia, there
is a protective factor against the occurrence of death in patients with sepsis, as it was
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shown that the risk of death in the mild hyponatremia group is lower than that in the
normonatremi group.
Monitoring sodium levels in septic patients can be useful for avoiding dysnatremia
caused by excessed fluid therapy or a lack of fluid therapy, and to avoid clinical outcomes
in the form of death.Further research can be done by taking more complete additional
parameters, scoring data for clinical diagnosis of sepsis and exclusion of diagnosis that
can affect the levels of the parameters studied.
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